This review of the association between cannabis use and periodontal disease includes 5 observational studies and suggests a positive relationship.
[read the full story...]
This review of the association between cannabis use and periodontal disease includes 5 observational studies and suggests a positive relationship.
[read the full story...]
Joe Barnby considers the findings of a recent meta-analysis of cross-sectional observational data, which explores the association of cannabis with cognitive functioning in adolescents and young adults.
[read the full story...]
Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.
[read the full story...]
As we prepare for our Cannabis #MHQT event on Wed 26 Sep, Luke Sheridan Rains dissects a narrative review that asks: Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?
His answer is that current evidence does not support the use of medical cannabis for mental illnesses such as anxiety or depression.
[read the full story...]
Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.
[read the full story...]
James MacCabe appraises a recent study, which looks at the association of combined patterns of tobacco and cannabis use in adolescents who go on to experience psychotic symptoms.
[read the full story...]
Thomas Richardson looks at a recent prospective cohort study in the British Journal of Psychiatry on adolescent cannabis use, baseline prodromal symptoms and the risk of psychosis.
[read the full story...]
Ian Hamilton and Suzi Gage explain why we know so little about the relationship between cannabis and severe mental illness in women.
[read the full story...]
Marcus Munafo considers the findings of a systematic review of meta-analyses of observational studies, which looks at risk factors and peripheral biomarkers for psychotic disorders on the schizophrenia spectrum.
[read the full story...]
Thomas Richardson writes his debut blog about a recent prospective analysis of poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis.
[read the full story...]